by TeraRecon, on Nov 14, 2023 8:02:13 AM
CAMBRIDGE, Mass., Nov. 14, 2023 /PRNewswire/ -- Today, ConcertAI, the leader in oncology Real-World Data (RWD), Digital Accelerated Clinical Trial solutions, and Clinical Artificial Intelligence imaging interpretation, announced a multi-year …
Read Storyby TeraRecon, on Oct 17, 2023 10:28:59 AM
CAMBRIDGE, Mass., Oct. 17, 2023 /PRNewswire/ -- ConcertAI's TeraRecon, the advanced visualization and clinical AI SaaS company, announced today its strategic collaboration with Optellum Ltd (Oxford, UK), a global leader …
Read Storyby TeraRecon, on Aug 2, 2023 12:13:01 PM
CAMBRIDGE, Mass., Aug. 2, 2023 /PRNewswire/ -- ConcertAI's TeraRecon, the advanced visualization and clinical AI SaaS company, announced today the integration of MiradaXD, the multi-modality nuclear medicine imaging software by …
Read Storyby TeraRecon, on Apr 3, 2023 12:22:58 PM
CAMBRIDGE, Mass., April 3, 2023 /PRNewswire/ -- The Eureka Clinical AI platform, from ConcertAI's TeraRecon, now provides clinicians with the state-of-the-art artificial intelligence and deep learning technology necessary to automatically …
Read StoryTeraRecon is a leader in advanced visualization, artificial intelligence, image viewing, and post-processing.
TeraRecon Headquarters
4309 Emperor Blvd, Suite 310
Durham, NC 27703
Tel: 650.372.1100
Fax: 650.372.1101
info@terarecon.com
All offerings are subject to availability and regulatory clearance, which may vary by country. Please verify product status with your local TeraRecon representative.